Busca avançada
Ano de início
Entree


In silico investigation of heparanase-correlated genes in breast cancer subtypes

Texto completo
Autor(es):
Melo, Carina Mucciolo ; Prado, Henrique Pereira ; Attie, Gabriela Araujo ; Ruiz, Daniel Lacaz ; Batista Castello Girao, Manoel Joao ; da Silva Pinhal, Maria Aparecida
Número total de Autores: 6
Tipo de documento: Artigo Científico
Fonte: Einstein (São Paulo); v. 18, p. 7-pg., 2020-01-01.
Resumo

Objective: To investigate the possible genes that may be related to the mechanisms that modulate heparanase-1. Methods: The analysis was conducted at Universidade Federal de Sao Paulo, on the data provided by: The Cancer Genome Atlas, University of California Santa Cruz Genome Browser, Kyoto Encyclopedia of Genes and Genomes Pathway Database, Database for Annotation, Visualization and Integrated Discovery Bioinformatics Database and the softwares cBioPortal and Ingenuity Pathway Analysis. Results: Using messenger RNA expression pattern of different molecular subtypes of breast cancer, we proposed that heparinase-1 was co-related with its progression. In addition, genes that were analyzed presented co-expression with heparanase-1. The results that showed that heparanase-1 co-expressed with phosphoinositide 3-kinase adapter protein 1, sialic acid-binding immunoglobulin-like lectin 7, and leukocyte-associated immunoglobulin-like receptor 1 are directed related with immune system evasion during breast cancer progression. Furthermore, cathepsin L was co-expressed with heparanase-1 and transformed inactive heparanase-1 form into active heparanase-1, triggering extracellular matrix remodeling, which contributes to enhanced tumor-host interaction of the tumor. Conclusion: The signaling pathway analysis using bioinformatics tools gives supporting evidence of possible mechanisms related to breast cancer development. Evasion genes of the immune system co-expressed with heparanase-1, a enzyme related with tumor progression. (AU)

Processo FAPESP: 16/01357-8 - Peptídeos ligantes de heparam sulfato, heparanase e HER2 com potencial efeito antitneoplásico
Beneficiário:Maria Aparecida da Silva Pinhal
Modalidade de apoio: Auxílio à Pesquisa - Regular